ArticleNature communications2026

Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial.

Hejia Henry Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.